About 10 results found for searched term "84-16-2" (0.105 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3333 | Hexestrol | Estrogen Receptor |
| Bibenzyl | ||
| Hexestrol binds to ERα and ERβ with EC50 of 0.07 nM and 0.175 nM, respectively. | ||
| M7326 | SR 142948 | Others |
| SR 142948 is a highly potent NT receptor antagonist. | ||
| M8205 | SR 142948A | Others |
| SR 142948A is a non-peptide Neurotensin receptor antagonist. | ||
| M8414 | MJN110 | MAGL |
| MJN110 is an orally effective and selective inhibitor of monacylglycerol lipase (MAGL) with IC50 of 9.1 nM and 2.1 nM against hMAGL and 2-arachidonic triglyceride (2-AG), respectively. It has strong anti-hyperalgesia activity. | ||
| M8506 | ML351 | Lipoxygenase |
| ML351 is a cell penetrant, selective and highly potent human lipoxygenase-12/15 (15-Lipoxygenase-1, 12/15-LOX) inhibitor that exhibits protective effects against oxidative glutamate toxicity in mouse neuronal HT22 cells. | ||
| M18584 | Eleutheroside B1 | Others |
| Eleutheroside B1 | ||
| M20965 | FDL169 | CFTR |
| FDL169 is a CFTR corrector that is designed to fix and restore the function of the defective CFTR protein. | ||
| M25256 | Lexatumumab | Apoptosis |
| HGS-ETR 2 ETR2-ST01 Anti-Human ERBB3 Recombinant Antibody | ||
| Lexatumumab (HGS-ETR 2) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. Lexatumumab can be used for malignant pleural mesothelioma (MPM) research. | ||
| M49795 | ALC-0159 | Liposome |
| ALC-0159 is a lipid conjugate of polyethylene glycol that can be used as an excipient for vaccines. | ||
| M54418 | FC131 TFA | CXCR |
| FC131 TFA is a CXCR4 antagonist, inhibits [125I]-SDF-1 binding to CXCR4, with an IC50 of 4.5 nM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
